BRCA2 and breast cancer: The present review aims to investigate the current knowledge about BRCA2 mutations in canine cancer and the consequence of identified polymorphisms on the interaction with RAD51 protein and discuss the potential of applying synthetic lethality in the treatment of canine mammary tumors.